2023
DOI: 10.1016/j.hbpd.2022.09.010
|View full text |Cite
|
Sign up to set email alerts
|

Apolipoprotein E2 inhibits mitochondrial apoptosis in pancreatic cancer cells through ERK1/2/CREB/BCL-2 signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…This signaling cascade entails the activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2), which subsequently activate the transcription factor known as cAMP response element-binding protein (CREB). Upon activation, CREB initiates the expression of various target genes, including Bcl-2, a protein well-known for its anti-apoptotic properties [ 52 ].…”
Section: Discussionmentioning
confidence: 99%
“…This signaling cascade entails the activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2), which subsequently activate the transcription factor known as cAMP response element-binding protein (CREB). Upon activation, CREB initiates the expression of various target genes, including Bcl-2, a protein well-known for its anti-apoptotic properties [ 52 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, APOE expression was found to be higher in pancreatic cancer tissue than in normal pancreatic tissue, and that elevated APOE levels are linked to worse outcomes for pancreatic cancer patients [128,129]. In addition, APOE2 has been found to aid pancreatic cancer cells in avoiding mitochondrial apoptosis by regulating the mitochondrial localization and expression of BCL-2 through the activation of the ERK1/2/CREB signaling cascade [130]. A study found that pancreatic cancer cell proliferation is associated with increased expression of APOE2-LRP8, a ligandreceptor pair that promotes tumor progression.…”
Section: Apolipoproteins In Pancreatic Cancermentioning
confidence: 99%